Skip to content

Grifols SA

GIFLF GIFOF GIKLY GRFS

CIK 0001438569 · Pharmaceutical Preparations · Nasdaq, OTC, OTC, OTC

← back to feed
Revenue (TTM)
€7.21B
+9.4% YoY FY Dec 2024
Net Income (TTM)
€212.81M
+30.0% YoY FY Dec 2024
EPS Diluted (TTM)
€0.23
+283.3% YoY FY Dec 2024
Gross Margin
38.7%
FY Dec 2024
Operating Margin
16.5%
FY Dec 2024
Net Margin
3.0%
FY Dec 2024
Free Cash Flow (TTM)
—
FY Dec 2024
Cash
€979.78M
FY Dec 2024
Total Debt
—
FY Dec 2024
Shares Outstanding
—
FY Dec 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings